Get started
Author

Balázs Jóri

Observed names: B Jóri, B. Jori, B. Jóri, Balazs Jori, Balazs Jóri, Jori B
ORCID: 0000-0003-1281-9526
Observed ORCID: 0000-0003-1281-9526
OpenAlex ID: A5019154044
Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas
2011 · Balázs Szabó, Györgyi A. Nelhűbel, et al. · Oral Oncology · 92
Epidermal Growth Factor Receptor (EGFR) High Gene Copy Number and Activating Mutations in Lung Adenocarcinomas Are Not Consistently Accompanied by Positivity for EGFR Protein by Standard Immunohistochemistry
2008 · Ferenc Pinter, Judit Papay, et al. · Journal of Molecular Diagnostics · 63
Role of transporters in paraquat resistance of horseweed Conyza canadensis (L.) Cronq.
2006 · Balázs Jóri, Vilmos Soós, et al. · Pesticide Biochemistry and Physiology · 34
Development of the NOGGO GIS v1 Assay, a Comprehensive Hybrid-Capture-Based NGS Assay for Therapeutic Stratification of Homologous Repair Deficiency Driven Tumors and Clinical Validation
2023 · Eva-Maria Willing, Claudia Vollbrecht, et al. · Cancers · 31
PDF
High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer
2016 · Karlijn M.C. Cornel, Camilla Krakstad, et al. · Molecular and Cellular Endocrinology · 26
Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy
2021 · Balázs Jóri, Stefanie Schatz, et al. · Cancers · 18
PDF
Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer
2020 · Stefanie Schatz, Markus Falk, et al. · Cancers · 16
PDF
Acquired G2032R Resistance Mutation in ROS1 to Lorlatinib Therapy Detected with Liquid Biopsy
2022 · Balázs Jóri, Markus Falk, et al. · Current Oncology · 13
PDF
Secondary ROS1 mutations and lorlatinib sensitivity in crizotinib-refractory ROS1 positive NSCLC: Results of the prospective PFROST trial
2019 · L. Landi, M. Tiseo, et al. · Annals of Oncology · 11
Germ-line variants identified by next generation sequencing in a panel of estrogen and cancer associated genes correlate with poor clinical outcome in Lynch syndrome patients
2015 · Balazs Jóri, Rick Kamps, et al. · Oncotarget · 9
PDF
Ferritin2 gene in paraquat-susceptible and resistant biotypes of horseweed Conyza canadensis (L.) Cronq.
2005 · Vilmos Soós, Balázs Jóri, et al. · Journal of Plant Physiology · 8
The Combined Therapy of Cabozantinib, Crizotinib, and Osimertinib in a Lung Cancer Patient with Acquired MET Amplification and Resistance Mutations
2023 · Balázs Jóri, Christine Vössing, et al. · Current Oncology · 6
PDF
Intracranial response to capmatinib after progression on crizotinib in a patient with MET exon 14 skipping non-small cell lung cancer—a case report
2024 · Balázs Jóri, Otto Bundschuh, et al. · Translational Lung Cancer Research · 4
Effect of transporter inhibitors on paraquat resistance of horseweed (Conyza canadensis /L./ Cronq.)
2002 · Krisztián Halász, Vilmos Soós, et al. · Acta Biologica Szegediensis · 4
2022-RA-873-ESGO Validation study of the ‘NOGGO-GIS ASSAY’ based on ovarian cancer samples from the first-line PAOLA-1/ENGOT-ov25 phase-III trial
2022 · Eva-Maria Willing, Claudia Vollbrecht, et al. · International Journal of Gynecological Cancer · 3
PDF
Role of transporters in the mechanism of paraquat resistance of horseweed (Conyza canadensis (L.) Cronq.)
2005 · Vilmos Soós, Balázs Jóri, et al. · Acta Biologica Szegediensis · 3
P1.14-03 Molecular Determinants for Lorlatinib Activity in ROS1 Positive NSCLC: Results of the Prospective PFROST Trial
2019 · L. Landi, M. Tiseo, et al. · Journal of Thoracic Oncology · 1
PDF
V-236 Molekulare Diagnostik des Lungenkarzinoms zur Differenzierung zwischen Metastase und synchronem Zweitkarzinom
2021 · Petra Hoffknecht, Sabine Voigt, et al. · Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie
1246P Hybrid capture-based assays in primary diagnostics of NSCLC patients: Results from the NEOlung study
2020 · B. Jori, O. Gautschi, et al. · Annals of Oncology
PDF
Immunodeficiency, Centromeric Instability and Facial Dysmorphism Syndrome: A Case Report
2019 · Alonazi NA, Mohamed S, et al. · Journal of Clinical Case Reports
PDF
Triple Diagnosis established by Whole Exome Sequencing
2017 · Peter Bauer, Zafer Yüksel, et al.
Increased 17beta-hydroxysteroid dehydrogenase type 1 mRNA level is correlated with poor prognosis in endometrial cancer
2016 · Karlijn Cornel, Camilla Krakstad, et al. · Endocrine Abstracts
PDF
51P Multiple Primary Neoplasia, or a Neoplasia with Satellites? The Role of Molecular Biology in The Diagnostic Process
2012 · D. Deme, C. Székely, et al. · Annals of Oncology
PDF
Signal transduction therapy of colon tumors with multiple target kinase inhibitors
2009 · G Kéri, L Őrfi, et al. · Zeitschrift für Gastroenterologie
Expression Analysis of ABC Transporters in Lung Cancer Cell Lines Using a RealTime ready qPCR Focus Panel
2009 · Balázs Jóri, Helga Barti-Juhász, et al.
Works count: 26
Citation count: 342
H-index: 9
I10-index: 9
Year
Topic
Type